Frazier Lifesciences Acquisition Corp. (FLAC)
| Market Cap | 163.58M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 14.93M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 19 |
| Last Price | $10.96 |
| Previous Close | $11.30 |
| Change ($) | -0.34 |
| Change (%) | -3.01% |
| Day's Open | - |
| Day's Range | 10.89 - 11.03 |
| Day's Volume | 0 |
| 52-Week Range | 0.00 - 11.03 |
News
MENLO PARK, Calif.--(BUSINESS WIRE)--Frazier Healthcare Partners' special purpose acquisition corporation, Frazier Lifesciences Acquisition Corporation, announced the pricing of its initial pu...
Frazier Lifesciences Acquisition, a blank check company formed by Frazier Healthcare Partners targeting the biotech industry, filed on Friday with the SEC to raise up to $100 million in an ini...
Frazier Lifesciences Acquisition Corp. has filed to go public with an IPO on the NASDAQ.
About FLAC
Frazier Lifesciences Acquisition is a newly organized blank check company incorporated on October 7, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. While we may pursue an initial business combination opportunity in any business, industry, sector or geographical location, we intend to capitalize on the ability of our management team to identify promising opportunities in the ... [Read more...]
| Industry Blank Checks / SPAC | IPO Date Dec 9, 2020 |
| CEO James N. Topper | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol FLAC |